echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Journal of Parkinson's Disease: People with Parkinson's should be vaccinated against COVID19

    Journal of Parkinson's Disease: People with Parkinson's should be vaccinated against COVID19

    • Last Update: 2021-02-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    February 4, 2021 // -- Patients and caregivers with Parkinson's disease (PD) have expressed concern about the efficacy and safety of the COVID-19 vaccine in PD and in the specific context of its treatment.
    comments just published in Journal of Parkinson's Disease, experts address these concerns from an evidence-based perspective.
    concluded that PD patients should be advised to use approved vaccines for COVID-19 vaccination unless there are specific taboos.
    (Photo: www.pixabay.com) "The arrival of these vaccines offers hope to PD patients because it can help reduce their risk of severe post-SARS-CoV-2 infection, which can lead to serious life-threatening diseases, at least in patients with late stages of PD.
    " first author, Bastiaan R. Bloem, M.D., of Nebuheng University's Nedgen Medical Center, explained.
    Based on the author's explanation of the scientific literature, the evolving experience of extensive vaccination in the general population, and the opinion of the International Parkinson's Society's Scientific Committee on Movement Disorders (IPMDS-SIC), the vaccination recommendations for COVID19 are as follows: IND patients (at least those with more severe conditions) appear to have a higher risk of serious and life-threatening diseases than the general population.
    not yet known or expected that approved mRNA-based and viral vector vaccines being developed will interact with neurodegenerative processes in PD.
    the type or rate of side effects of these vaccines in PD patients does not appear to be different from that of the general population.
    vaccine also appears to be safe for older people, special attention needs to be paid to special groups of people living in long-term care facilities with PD infirmity and terminal illness.
    't know that COVID-19 vaccination interferes with current treatments for PD.
    who receive PD vaccines must continue to follow public health guidelines to reduce the exposure and spread of COVID-19.
    "Taking into account all current evidence, we encourage the community of motion disorder specialists to recommend an approved vaccine for COVID-19 vaccination to their PD patients or responsible caregivers, with the exception of certain taboos."
    , even after vaccination, PD patients must continue to follow public health guidelines to reduce the risk of exposure and transmission of COVID-19 recommended by the World Health Organization and the Centers for Disease Control and Prevention.
    () Source: COVID-19 for patients with Parkinson's disease recommended original source: Bastiaan R. Bloem et al, COVID-19 For People with Parkinson's Disease: Light at at The End of the Tunnel?, Journal ofInson Park's Disease (2021). DOI: 10.3233/JPD-212573
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.